Procurement Summary
Country : Denmark
Summary : Contract notice: Pharmaceutical products
Deadline : 30 Aug 2018
Other Information
Notice Type : Tender
TOT Ref.No.: 24354303
Document Ref. No. : 265298-2018
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : AMGROS I/S
Office Name: Amgros I/S
Address: Dampfærgevej 22
Town: Copenhagen
Postal Code: 2100
Contact Point: Flemming Sonne
Phone: +45 88713000
Fax: +45 88713008
Denmark
Email :udbud@amgros.dk
URL :http://www.amgros.dk
Tender Details
Object of the contract
Pharmaceutical products
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.
Amgros 2019-1.852.a.
Amgros is a partnership with the 5 regions as stakeholders. In order to provide stakeholders' hospital pharmacies with drugs and the resale of individual stakeholders to the Faroe Islands and Greenland, Amgros I / S wishes to enter into framework agreements for the medicinal products listed in Section II.2.4. The framework agreements are non-exclusive. Amgros I / S reseller lowerthe funds for hospital pharmacies to Amgros I / S 'purchase price with an additional fee. Framework agreements are entered without specification, and hospital pharmacies in the regions are not obliged to apply Amgros' framework agreements.
Main Site: Place of delivery is the address of Amgros at the address (hospital pharmacy or affiliated locations).
The tender number includes the following medicines:
Offer No: 1,
ATC Code: J02AA01,
Generic name: Amphotericin conventional,
Dispensing form: Infusion bag,
Strength: 50 mg,
Unit value: 35 mg,
Quantity in units: 4 326.
The above medications are offered independently of the drugs under the remaining tender numbers. is considered a separate subcontract. A supplier will then be able to choose to bid on one or more or all tender numbers and assignmentSeparate for each tender number. Reference is made to the terms of reference, including the submission of tenders under the individual tender numbers.
The term "quantity in units" indicates the estimated consumption of the drugs under the tender number.
It is noted that this amount is based on historical consumption and that the suppliers I guess that the actual purchase under a framework agreement may differEssentially from there. Reference is made to the terms of the tender terms. 3.6 and the Framework Agreement Item. 2. The medicinal products must have a marketing authorization valid for Denmark no later than 30.8.2019 at. 12:00. Furthermore, at the time of the expiry of the deadline and during the duration of the framework agreement, the supplier shall be authorized to manufacture, import or wholesale pharmaceuticals within the EU/E0S.
Leveranders wishing to submit offers must use the standard form of the single European Procurement Document (ESPD) to issue a declaration of the compulsory grounds for exclusion in section 135-136 of the Procurement Act (Act No. 1564 of 15 December 2015 with amendments ). Further information on the completion and use of ESPD in the procurement process can be found in the instructions provided by Amgros herom and in the Competition and Consumer Agency's "Guide to the Single European Call Document". The winning supplier (s) that Amgros intends to award the framework agreement must, before the award, have made documentation available to Amgros in so far as the mandatory grounds for exclusion, cf. - 152 - 153 of the Procurement Act. Amgros can not exclude a supplier who er is subject to one or more of the mandatory grounds for exclusion in section 135-136 of the Public Procurement Act, the safeguard supplier may provide sufficient evidence that the supplier is, in any case, palpable, cf. section 138 of the Procurement Act. Amgros reserves the right to carry out such a self-cleaning process, safely if the mat is relevant.
No information required. II.2.3es that an overview of delivery sites is available on Amgros' Procurement and Procurement Portal, https://levportal.amgros.dk. The overview will be updated, as soon as possible, due to changes in food. II.2.4 notes that Amgros has considered whether the tender group can be further subdivided. Amgros has realized that this is not the case in the light of considerations of economies of scale that do note will be achievable by a further breakdown as well as costs and patient safety considerations related to the subsequent contract and drug handling. II.1.5 and point II.2.6 noted that the estimated value in section. II.1.5 is the total estimated value of all tender numbers (lots) in the duration of the framework agreement incl. possibility of extension, cf. II.20.7. In section II.2.6 is the estimated value of each tender number incl. possibility of extension given, cf. II.2.7.
It should also be noted that the estimated value is based on historical consumption and that the actual purchase may therefore deviate significantly therefrom, cf. II.2.4, Item No. of the Terms and Conditions. 3.6 and the Framework Agreement Item. 2. The questionnaire for the tender documents must be submitted in the tender systemone, cf. the terms of the terms of reference.
Access to tender requires that the company be established as a user of Amgros' procurement system. There may be some processing days associated with user creation, and it is therefore inconceivable for any bidders to do so in good time. Reference is made to information related to the procurement system, including the user guide.
In relation ton to pt. IV.2.4 notes that some parts of the offer may also be in English. Reference is made to the terms of the tender terms. 4.1.
In relation to point VI.2 noted that electronic invoicing is required
Internet address (URL): http://www.amgros.dk
Directive: Classical Directive (2014/24/EU)
Documents
Tender Notice